China Universal Asset Management Co., Ltd. Dyne Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,573 shares of DYN stock, worth $535,711. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,573
Previous 15,573
-0.0%
Holding current value
$535,711
Previous $442,000
-0.0%
% of portfolio
0.06%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding DYN
# of Institutions
176Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$276 Million28.49% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$270 Million31.49% of portfolio
-
Black Rock Inc. New York, NY5.39MShares$185 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$157 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$146 Million0.02% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.78B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...